参考文献
［1］Min Y，Caster J M，Eblan M J，et al.Clinical translation of nanomedicine［J］.Chem Rev，2015，115（19）：11147-11190.
［2］Gelderblom H，Verweij J，Nooter K，et al.Cremophor EL：the drawbacks and advantages of vehicle selection for drug formulation［J］.Eur J Cancer，2001，37（13）：1590-1598.
［3］Xing J，Zhang D，Tan T.Studies on the oridonin-loaded poly（D，L-lactic acid）nanoparticles in vitro and in vivo［J］.Int J Biol Macromol，2007，40（2）：153-158.
［4］Yoo H S，Oh J E，Lee K H，et al.Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release［J］.Pharm Res，1999，16（7）：1114-1118.
［5］Bhadra D，Bhadra S，Jain S，et al.A PEGylated dendritic nanoparticulate carrier of fluorouracil［J］.Int J Pharm，2003，257（1-2）：111-124.
［6］Kono K，Kojima C，Hayashi N，et al.Preparation and cytotoxic activity of poly（ethylene glycol）-modified poly（amidoamine）dendrimers bearing adriamycin［J］.Biomaterials，2008，29（11）：1664-1175.
［7］Moura L A，Ribeiro F V，Aiello T B，et al.Characterization of the release profile of doxycycline by PLGA microspheres adjunct to non-surgical periodontal therapy［J］.J Biomat Sci Polym Ed，2015，26（10）：573-584.
［8］Nam Y S，Kim J W，Park J，et al.Tocopheryl acetate nanoemulsions stabilized with lipid-polymer hybrid emulsifiers for effective skin delivery［J］.Colloids Surf B Biointerfaces，2012，94：51-57.
［9］Liang R，Dong L，Deng R，et al.Surfactant-free biodegradable polymeric nanoparticles generated from self-organized precipitation route：cellular uptake and cytotoxicity［J］.Eur Polym J，2014，57：187-201.
［10］Sadighian S，Hosseini-Monfared H，Rostamizadeh K，et al.pH-triggered magneticchitosan nanogels（MCNs）for doxorubicin delivery：physically vs.chemically cross linking approach［J］.Adv Pharm Bull，2015，5（1）：115-120.
［11］Liang R，Wang J，Wu X，et al.Multifunctional biodegradable polymer nanoparticles with uniform sizes：generation and in vitro anti-melanoma activity［J］.Nanotechnology，2013，24（45）：455302.
［12］Ventura C A，Tommasini S，Crupi E，et al.Chitosan microspheres for intrapulmonary administration of moxifloxacin：interaction with biomembrane models and in vitro permeation studies［J］.Eur J Pharm Biopharm，2008，68（2）：235-244.
［13］Gormley A J，Chandrawati R，Christofferson A J，et al.Layer-by-layer self-assembly of polymer films and capsules through coiled-coil peptides［J］.Chem Mater，2015，27（16）：5820-5824.
［14］Liu Y，Li Y，He J，et al.Entropy-driven pattern formation of hybrid vesicular assemblies made from molecular and nanoparticle amphiphiles［J］.J Am Chem Soc，2014，136（6）：2602-2610.
［15］Wang S，Yu G，Wang Z，et al.Hierarchical tumor microenvironment-responsive nanomedicine for programmed delivery of chemotherapeutics［J］.Adv Mater，2018，30（40）：e1803926.
［16］D'Souza S S，DeLuca P P.Methods to assess in vitro drug release from injectable polymeric particulate systems［J］.Pharm Res，2006，23（3）：460-474.
［17］Beriro D J，Cave M R，Wragg J，et al.A review of the current state of the art of physiologically-based tests for measuring human dermal in vitro bioavailability of polycyclic aromatic hydrocarbons（PAH）in soil［J］.J Hazard Mater，2016，305：240-259.
［18］Qiu H，Gao Y，Boott C E，et al.Uniform patchy and hollow rectangular platelet micelles from crystallizable polymer blends［J］.Science，2016，352（6286）：697-701.
［19］Bruschi M L.Strategies to modify the drug release from pharmaceutical systems［M］.London：Woodhead Publishing，2015.
［20］Proksch E.pH in nature，humans and skin［J］.J Dermatol，2018，45（9）：1044-1052.
［21］Grumezescu A.Nanoscale fabrication，optimization，scale-up and biological aspects of pharmaceutical nanotechnology［M］.Amsterdam：Elsevier Academic Press，2018.
［22］Garbe C，Eigentler T K，Keilholz U，et al.Systematic review of medical treatment in melanoma：current status and future prospects［J］.Oncologist，2011，16（1）：5-24.
［23］Avril M F，Aamdal S，Grob J T，et al.Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma：a phase Ⅲ study［J］.J Clin Oncol，2004，22（6）：1118-1125.
［24］Liu Q，Das M，Liu Y，et al.Targeted drug delivery to melanoma［J］.Adv Drug Deliver Rev，2018，127：208-221.
［25］Golombek S K，May J N，Theek B，et al.Tumor targeting via EPR：strategies to enhance patient responses［J］.Adv Drug Deliver Rev，2018，130：17-38.
［26］Blanco E，Shen H，Ferrari M.Principles of nanoparticle design for overcoming biological barriers to drug delivery［J］.Nat Biotechnol，2015，33（9）：941-951.(https://www.daowen.com)
［27］Zhang Y R，Lin R，Li H J，et al.Strategies to improve tumor penetration of nanomedicines through nanoparticle design［J］.Wiley Interdiscip Rev Nanomed Nanobiotechnol，2019，11（1）：e1519.
［28］Cabral H，Makino J，Matsumoto Y，et al.Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled nano carriers［J］.ACS Nano，2015，9（5）：4957-4967.
［29］Du X J，Wang J L，Liu W W，et al.Regulating the surface poly（ethylene glycol）density of polymeric nanoparticles and evaluating its role in drug delivery in vivo［J］.Biomaterials，2015，69：1-11.
［30］Lu Y，Yue Z，Xie J，et al.Micelles with ultralow critical micelle concentration as carriers for drug delivery［J］.Nat Biomed Eng，2018，2（5）：318-325.
［31］Ling X，Shen Y，Sun R，et al.Tumor-targeting delivery of hyaluronic acid-platinum（Ⅳ）nanoconjugate to reduce toxicity and improve survival［J］.Polym Chem，2015，6（9）：1541-1552.
［32］Guo Y，Niu B，Song Q，et al.RGD-decorated redox-responsive D-a-tocopherol polyethylene glycol succinate-poly（lactide）nanoparticles for targeted drug delivery［J］.J Mater Chem B，2016，4（13）：2338-2350.
［33］Dai L，Li K，Li M，et al.Size/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration［J］.Adv Funct Mater，2018，28（18）：1707249.
［34］Talelli M，Iman M，Varkouhi A K，et al.Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin［J］.Biomaterials，2010，31（30）：7797-7804.
［35］Zhao D，Wu J，Li C，et al.Precise ratiometric loading of PTX and DOX based on redoxsensitive mixed micelles for cancer therapy［J］.Colloid Surface B Biointerfaces，2017，155：51-60.
［36］Liu M，Zhang P，Deng L，et al.IR780-based light-responsive nanocomplexes combining phase transition for enhancing multimodal imaging-guided photothermal therapy［J］.Biomater Sci，2019，7（3）：1132-1146.
［37］Wallat J D，Wek K S，Chariou P L，et al.Fluorinated polymer-photosensitizer conjugates enable improved generation of ROS for anticancer photodynamic therapy［J］.Polym Chem，2017，8（20）：3195-3202.
［38］Liu Y，Bhattarai P，Dai Z，et al.Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer［J］.Chem Soc Rev，2019，48（7）：2053-2108.
［39］Ding H，Yu H，Dong Y，et al.Photoactivation switch from type Ⅱ to type Ⅰ reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia［J］.J Control Release，2011，156（3）：276-280.
［40］Rogers S J，Puric E，Eberle B，et al.Radiotherapy for melanoma：more than DNA damage［J］.Dermatology Research and Practice，2019，2019：9435389.
［41］Gu X，Zhu Z，Fan Q，et al.Nanoagents based on poly（ethylene glycol）-b-poly（lthyroxine）block copolypeptide for enhanced dual-modality imaging and targeted tumor radiotherapy［J］.Small，2019，15（45）：e1902577.
［42］Sindhwani S，Syed A M，Ngai J，et al.The entry of nanoparticles into solid tumours［J］.Nat Mater，2020，19（5）：566-575.
［43］Pradhan M，Alexander A，Singh M R，et al.Understanding the prospective of nanoformulations towards the treatment of psoriasis［J］.Biomed Pharmacother，2018，107：447-463.
［44］Du H，Liu P，Zhu J，et al.Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis［J］.ACS Appl Mater Interfaces，2019，11（46）：43588-43598.
［45］Jin Y，Zhang X，Zhang B，et al.Nanostructures of an amphiphilic zinc phthalocyanine polymer conjugate for photodynamic therapy of psoriasis［J］.Colloid Surface B Biointerfaces，2015，128：405-409.
［46］Cevc G，Vierl U.Nanotechnology and the transdermal route a state of the art review and critical appraisal［J］.J Control Release，2010，141（3）：277-299.
［47］Zhang Y，Xia Q，Li Y，et al.CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes：a new strategy for clustering drug in inflammatory skin［J］.Theranostics，2019，9（1）：48-64.
［48］Dolz-Pérez I，Sallam M，Masiá E，et al.Polypeptide-corticosteroid conjugates as a topical treatment approach to psoriasis［J］.J Control Release，2020，318：210-222.
［49］Shetty P K，Venuvanka V，Jagani H V，et al.Development and evaluation of sunscreen creams containing morin-encapsulated nanoparticles for enhanced UV radiation protection and antioxidant activity［J］.Int J Nanomed，2015，10：6477-6491.
［50］Ali I，Alsehli M，Scotti L，et al.Progress in polymeric nano-medicines for theranostic cancer treatment［J］.Polymers（Basel），2020，12（3）：598.
（邓仁华 刘奕静 李钰策）